ASCENT (Aggressive Smoldering Curative Approach Evaluating Novel Therapies and Transplant) Trial Management
High-risk Smoldering Multiple Myeloma (SMM)
Not Applicable (Service Provider)Active
Key Facts
Indication
High-risk Smoldering Multiple Myeloma (SMM)
Phase
Not Applicable (Service Provider)
Status
Active
Company
About Trevie Research
Trevie Research is a privately held, US-based contract research organization founded in 2019 and headquartered in San Diego, with additional offices in Cambridge, MA, and Los Angeles, CA. It operates as a service provider in the biotech sector, offering specialized clinical trial management and development advisory services exclusively for oncology and immunology, with a noted partnership in the high-profile ASCENT trial for smoldering multiple myeloma. The company targets early-stage biopharma clients, leveraging its academic and KOL networks to provide a more tailored and potentially cost-effective alternative to larger CROs.
View full company profile